Iradimed
Open
$83.14
Prev. Close
$83.02
High
$83.64
Low
$83.09
Market Snapshot
$1.06B
47.4
1.53
$73.24M
166
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 166 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Iradimed projects a Q1 EPS of $0.45 and $21.32 million in revenue, indicating strong annual growth in the medical device industry.
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 166 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Recently from Cashu
Iradimed CEO's Insider Sale Sparks Questions on Confidence and Company Outlook
Iradimed's Insider Sale: A Sign of Confidence or Concern? In a recent development within Iradimed Corporation, CEO Roger E. Susi makes headlines following his significant insider sale reported in an S…
Iradimed (IRMD): Innovating Healthcare Technology for Enhanced Patient Safety and Care Quality
Iradimed's Commitment to Innovation in Healthcare Technology Iradimed Corporation, a leader in MRI-compatible intravenous (IV) infusion systems, maintains its focus on advancing patient safety and enh…
Iradimed CEO's Insider Sale Sparks Speculation Amidst Healthcare Innovation
Iradimed's Leadership Moves Amidst Innovative Healthcare Developments In a recent filing with the Securities and Exchange Commission (SEC), iRadimed Corporation's CEO, Roger E. Susi, reports an inside…
CEO Insider Sale Raises Questions on iRadimed's Strategic Future and Market Confidence
CEO Insider Sale Sparks Interest in iRadimed's Strategic Direction In a recent filing with the Securities and Exchange Commission (SEC), Roger E. Susi, the CEO of iRadimed Corporation, discloses an in…